144 related articles for article (PubMed ID: 13061942)
1. Some clinical experience in the use of triethylene melamine (TEM).
HAMERMAN DJ; MELAMED S
J Mt Sinai Hosp N Y; 1953; 20(1):16-26. PubMed ID: 13061942
[No Abstract] [Full Text] [Related]
2. [Triethylenemelamine (TEM) in lymphatic leukemia].
PRIBILLA W; STOLLBERG G
Munch Med Wochenschr; 1954 Oct; 96(41):1189-91. PubMed ID: 13223716
[No Abstract] [Full Text] [Related]
3. Treatment of polycythemia vera with triethylene melamine; summary of thirty cases.
ROSENTHAL N; ROSENTHAL RL
AMA Arch Intern Med; 1952 Sep; 90(3):379-88. PubMed ID: 14952061
[No Abstract] [Full Text] [Related]
4. Triethylenemelamine in polycythemia vera; a therapeutic trial.
ELLISON RR; GINSBERG V; WATSON J
Cancer; 1953 Mar; 6(2):327-32. PubMed ID: 13032924
[No Abstract] [Full Text] [Related]
5. Triethylene melamine (TEM) in the treatment of malignant lymphoid disease.
HAMBLY CK; ROBERTSON TI
Med J Aust; 1955 Jun; 42(1 25):900-11. PubMed ID: 13243982
[No Abstract] [Full Text] [Related]
6. The immediate action of triethylene melamine in chronic lymphatic leuchaemia.
BOLTON JH; BEAN RH
Med J Aust; 1954 Sep; 2(12):474-8. PubMed ID: 13213377
[No Abstract] [Full Text] [Related]
7. [Thirty cases of chronic leukemic lymphadenosis treated with intravenous administration of triethylene melamine].
GIGANTE D; ZOPPINI A
Prog Med (Napoli); 1956 Jun; 12(12):361-8. PubMed ID: 13350408
[No Abstract] [Full Text] [Related]
8. The clinical use of triethylene melamine.
KRAVITZ SC; DIAMOND HD; CRAVER LF
Blood; 1952 Jul; 7(7):729-42. PubMed ID: 14934758
[No Abstract] [Full Text] [Related]
9. [Treatment of hemoblastosis with triethylene melamine].
LINKE A; LASCH HG
Dtsch Med Wochenschr; 1953 Jun; 78(25):911-6. PubMed ID: 13068032
[No Abstract] [Full Text] [Related]
10. Triethylene melamine in the treatment of neoplastic disease.
RUNDLES RW; BARTON WB
Blood; 1952 May; 7(5):483-507. PubMed ID: 14925143
[No Abstract] [Full Text] [Related]
11. [Fatal uremia after triethylenemelamine treatment in chronic lymphatic leukemia].
MARTIN H
Klin Wochenschr; 1953 Mar; 31(11-12):263-6. PubMed ID: 13070457
[No Abstract] [Full Text] [Related]
12. [Our experience with the application of triethylene melamine (TEM) in patients with malignant hemopathies].
RUVIDIC R; NIKOLIC J
Med Glas; 1960 Sep; 14():435-42. PubMed ID: 13744964
[No Abstract] [Full Text] [Related]
13. [Clinical trials with triethylene melamine].
FERRARI M; KASDORF H
Arch Urug Med Cir Espec; 1953; 42(3-4):134-44. PubMed ID: 14350952
[No Abstract] [Full Text] [Related]
14. [Additional occurrence of carcinoma in a malignant disease treated with triethylene melamine].
LUHRS W; SCHAMMEL J; LOTZ HH
Z Gesamte Inn Med; 1954 Mar; 9(6):295-9. PubMed ID: 13170253
[No Abstract] [Full Text] [Related]
15. [Considerations on a case of leukosarcomatosis].
FUSCO FA
Arch Maragliano Patol Clin; 1956 Jun; 12(3):499-532. PubMed ID: 13363614
[No Abstract] [Full Text] [Related]
16. Total-body x-ray therapy of chronic lymphatic leukemia and polycythemia.
FINZE H
Strahlentherapie; 1956; 101(1):88-94. PubMed ID: 13391338
[No Abstract] [Full Text] [Related]
17. [Cytostasis due to triethylene melamine (TEM) in lymphogranulomatosis and chronic leukemia].
NEUMANN C
Klin Wochenschr; 1952 Dec; 30(47-48):1105-8. PubMed ID: 13023980
[No Abstract] [Full Text] [Related]
18. TREATMENT OF CHRONIC LEUKEMIC LYMPHOCYTIC LEUKEMIA WITH TRIETHYLENE MELAMINE (TEM) AND CHLORAMBUCIL (CB-1348).
BIGLEY RH
Cancer Chemother Rep; 1963 Jul; 30():27-30. PubMed ID: 14051500
[No Abstract] [Full Text] [Related]
19. Treatment of leukemia and lymphomata with triethylene melamine.
WALSH JR; PRATT PT; GRAHAM WE; ZIMMERMAN HJ
Acta Haematol; 1954 Jun; 11(6):329-38. PubMed ID: 13170978
[No Abstract] [Full Text] [Related]
20. [Therapy of malignant diseases of the blood with cortisone, triethylene melamine and the trace elements].
DUBOIS-FERRIERE H
Schweiz Med Wochenschr; 1951 Dec; 81(50):1235-7. PubMed ID: 14913076
[No Abstract] [Full Text] [Related]
[Next] [New Search]
